

Genzyme Oncology is focused on developing and commercializing novel treatments for cancer patients through promising internal research and active external collaborations. Genzyme Oncology's product development expertise and strong research program provide a solid base for building a sustainable and competitive oncology business.
Genzyme Oncology has a full pipeline of innovative drug candidates derived from diverse technologies. The combination of new, sophisticated molecular diagnostics with targeted therapeutics is considered hopeful in revolutionizing cancer treatment and improving patient outcomes.